Viralytics(VLA) used to be a $5m market cap biotech until it was taken over by Merck for $502m.
Did it all start with some kind of collaborative study? Eventually, Merck needed VLA's Cavatek drug in combination with its own drug, Keytruda for treating some types of cancers.
"Gliflozin drugs could be hugelybeneficial in improving patient outcomes from diabetes complications and welook forward to determining whether PromarkerD can help in assessing responsesto this treatment", said Dr Lipscombe
Has anyone researched Janssen's Gliflozen drugs?
TTC, you could well be right. If, it goes 10-100 bags it will be life changing for many. IMO, best strategy is to hold for the long term.
Viralytics(VLA) used to be a $5m market cap biotech until it was...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
-0.010(2.70%) |
Mkt cap ! $58.92M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.0¢ | 36.0¢ | $42.78K | 116.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1408 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 111109 | 2 |
View Market Depth
| Last trade - 13.47pm 31/07/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |